The CCK-8 assay showed that overexpression of ARNTL significantly enhanced the sensitivity while silencing of ARNTL substantially reduced the sensitivity of NPC cells to cisplatin in vitro (Fig. 7a-d). The gene discussed is BMAL1; the disease is nasopharyngeal carcinoma.